Literature DB >> 3533243

Effects of obtaining a blood culture on subsequent management of young febrile children without an evident focus of infection.

M S Kramer, E L Mills, A M MacLellan, P J Coates.   

Abstract

To assess the effects of obtaining a blood culture on the subsequent diagnostic and therapeutic management of young febrile children without an evident focus of bacterial infection, we carried out a randomized controlled clinical trial of this procedure in 146 children 3 to 24 months of age who presented to our emergency department with an unexplained temperature of 39.0 degrees C or higher. Random assignment to either have (67 children) or not have (79) a blood sample taken for culture resulted in groups equivalent in age, sex, weight, socioeconomic status, temperature at enrolment and laboratory test results. No differences were detected in the rates of subsequent hospital admission, outpatient visits, determination of complete blood count or other blood tests, urinalysis or urine culture, chest or other roentgenography, or administration of antibiotics or other medications. Knowledge of the absence of such differences should be helpful in evaluating the relative benefits and costs of blood culture for young febrile children.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533243      PMCID: PMC1491759     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  13 in total

1.  Bacteremia in febrile children under 2 years of age: results of cultures of blood of 600 consecutive febrile children seen in a "walk-in" clinic.

Authors:  D W Teele; S I Pelton; M J Grant; J Herskowitz; D J Rosen; C E Allen; R S Wimmer; J O Klein
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

2.  Bacteremia in children: an outpatient clinical review.

Authors:  P L McCarthy; G W Grundy; S Z Spiesel; T F Dolan
Journal:  Pediatrics       Date:  1976-06       Impact factor: 7.124

3.  C-reactive protein and zeta sedimentation ratio as indicators of bacteremia in pediatric patients.

Authors:  M Bennish; M O Beem; V Ormiste
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

4.  Bacteremia in febrile children seen in a "walk-in" pediatric clinic.

Authors:  J E McGowan; L Bratton; J O Klein; M Finland
Journal:  N Engl J Med       Date:  1973-06-21       Impact factor: 91.245

5.  Unsuspected bacteremia due to Haemophilus influenzae: outcome in children not initially admitted to hospital.

Authors:  R Marshall; D W Teele; J O Klein
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

6.  Bacteremia in private pediatric practice.

Authors:  M A Baron; H D Fink
Journal:  Pediatrics       Date:  1980-08       Impact factor: 7.124

7.  Relative importance of bacteremia and viremia in the course of acute fevers of unknown origin in outpatient children.

Authors:  D L Murray; J Zonana; J S Seidel; R N Yoshimori; D T Imagawa; J W St Geme
Journal:  Pediatrics       Date:  1981-08       Impact factor: 7.124

8.  Enhancement of recovery of Neisseria meningitidis by gelatin in blood culture media.

Authors:  C H Pai; S Sorger
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

9.  Occult bacteremia in toxic-appearing, febrile infants. A prospective clinical study in an office setting.

Authors:  R H Schwartz; R L Wientzen
Journal:  Clin Pediatr (Phila)       Date:  1982-11       Impact factor: 1.168

10.  Outcome of unsuspected pneumococcemia in children not initially admitted to the hospital.

Authors:  L Bratton; D W Teele; J O Klein
Journal:  J Pediatr       Date:  1977-05       Impact factor: 4.406

View more
  2 in total

1.  How do blood cultures sent from a paediatric accident and emergency department influence subsequent clinical management?

Authors:  P Leonard; T F Beattie
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

Review 2.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.